Lancaster Medicaid COVID-19 service claims total $11,911 in 2024

Dr. Mehmet Oz CMS Administrator
Dr. Mehmet Oz CMS Administrator
0Comments

In 2024, Lancaster Medicaid providers billed a minimum of $11,911 for services identified by HCPCS codes specific to COVID-19, based on data collected from the U.S. Department of Health and Human Services Medicaid Provider Spending database.

Medicaid is a government-funded insurance program operated by each state and funded by both federal and state governments. It provides coverage for low-income people, seniors, children and those with disabilities, making it a cornerstone of the U.S. health care system.

Since Medicaid relies on taxpayer funding, shifts in local claim activity shed light on how health care dollars are distributed within communities.

For this report, COVID-19–related services were defined using HCPCS codes labeled as “COVID-19” or “coronavirus” in billing details or official classifications. Therefore, these figures reflect only those services explicitly marked as COVID-related in billing and do not include all pandemic care that might be documented under other codes.

To put this data in perspective, Medicaid COVID-19–related claims in Pittsburgh totaled $266,441 in 2024, the highest in Pennsylvania.

Five providers in Lancaster submitted Medicaid claims for COVID-19–related services this year. The most utilized code was COVID Specific, responsible for $11,911 in approved charges.

On average, each Lancaster Medicaid provider received $2,382 for COVID-19–related services, which is below Pennsylvania’s statewide provider average of $6,645.

COVID-19–specific services drove significant parts of overall Medicaid spending increase in Lancaster through the pandemic period.

Total Medicaid spending across other claim categories rose by $92,116,008 from 2020 through 2024, marking a 386.8% rise.

In the two years leading up to the pandemic, Lancaster’s average annual Medicaid payouts were $6,346,569.

According to the Centers for Medicare & Medicaid Services, combined Medicaid spending from federal and state sources reached around $871.7 billion in fiscal 2023, roughly 18% of the nation’s total health expenditures, up from an estimated $613.5 billion in 2019 prior to the COVID-19 pandemic.

The 40% growth observed reflects both expanded enrollment and increased service use during the pandemic era and after.

Recent federal budget acts under the Trump presidency have advanced major reductions in federal Medicaid contributions and proposed structural program changes. The “One Big Beautiful Bill Act,” enacted in 2025, is projected to decrease federal Medicaid expenditures by over $1 trillion within the next decade and imposes provisions like work requirements and higher cost-sharing, potentially limiting coverage for certain beneficiaries. These policies could place more costs on states and cap increases to federal Medicaid support, although the program will still serve tens of millions nationwide.

Medicaid Payments in Lancaster Over 7 Years
Year COVID-19–Related Payments COVID-19 Payments % Change (YoY) Total Medicaid Payments
2024 $11,911 -71.1% $115,942,756
2023 $41,248 -86.9% $103,492,645
2022 $315,321 -86.6% $91,204,968
2021 $2,359,580 261.2% $83,948,032
2020 $653,210 N/A $24,468,046
2019 $0 N/A $6,229,002
2018 $0 N/A $6,464,137
Top COVID-19–Related HCPCS Codes in Lancaster
HCPCS Code Description Medicaid Payments Claims
87635 COVID Specific $11,911 313
90480 COVID-19 Vaccine Administration $0 77

Note: Includes HCPCS codes explicitly labeled for COVID-19 services; totals do not represent all pandemic-related health care spending.

This article’s information is drawn from the U.S. Department of Health and Human Services Medicaid Provider Spending database. The original data source appears here.



Related

Sean R. Keveney J.D., Chief Counsel of FDA

FDA cites Daud’s Specialties, LLC in Lancaster for 4 violations during March 18 inspection

Daud’s Specialties, LLC in Lancaster was inspected by the FDA on March 18 for food standards, labeling, economic factors and foodborne biological hazards, resulting in four violations.

Benjamin D. Moncarz Chief Financial Officer - FDA

Henry Schein, Inc. in Denver receives FDA inspection on April 2

On April 2, the FDA evaluated Henry Schein, Inc. in Denver, focusing on food composition, labeling, and foodborne biological hazards, based on information released on the FDA’s website.

Sridhar Mantha, Acting Chief Information Officer of FDA

FDA inspects Central Pennsylvania Blood Bank in Ephrata on March 11

The Central Pennsylvania Blood Bank in Ephrata was inspected by the FDA on March 11 regarding blood and blood product safety, based on information made available on the FDA’s website.